Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions
Authors:
- Jürgen KuballJKJürgen Kuball
- Matthias TheobaldMTMatthias Theobald
- Edite Antunes FerreiraEFEdite Antunes Ferreira
- Georg HessGHGeorg Hess
- Jürgen BurgJBJürgen Burg
- Giancarlo MaccagnoGMGiancarlo Maccagno
- Ana P BarreirosABAna P Barreiros
- Stefan LüthSLStefan Lüth
- Carl C SchimanskiCSCarl C Schimanski
- Markus SchuchmannMSMarkus Schuchmann
- Andreas SchwartingASAndreas Schwarting
- Markus NeurathMNMarkus Neurath
- 1 December 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 78 (12) , 1774-1779
Abstract
Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver–transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). Adoptive transfer of ex vivo activated alloreactive host T cells (aHLI) led to the control and complete resolution of severe GvHD without inducing allograft rejection. aHLI opens a novel therapeutic window to control solid-organ transplant-associated GvHD while preserving allograft integrity.Keywords
This publication has 28 references indexed in Scilit:
- Tolerogenic immunosuppression for organ transplantationThe Lancet, 2003
- Liver transplant-associated graft-versus-host diseaseTransplantation, 2003
- Transplantation tolerance from a historical perspectiveNature Reviews Immunology, 2001
- Factors affecting thymic function after allogeneic hematopoietic stem cell transplantationBlood, 2001
- Microchimerism in bone marrow–derived CD34+ cells of patients after liver transplantationBlood, 2000
- Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: Characteristics of the model and application to developing treatment strategiesTransplantation Proceedings, 1997
- CONFIRMATION OF GRAFT-VERSUS-HOST DISEASE AFTER LIVER TRANSPLANTATION BY PCR HLA-TYPINGTransplantation, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.Journal of Experimental Medicine, 1989
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974